DK0601001T3 - Flydende næringsmiddelprodukt indeholdende 3-guanidinopropionsyre. - Google Patents

Flydende næringsmiddelprodukt indeholdende 3-guanidinopropionsyre.

Info

Publication number: DK0601001T3
Authority: DK; Denmark
Prior art keywords: guanidinopropionic acid; pct; food product; insulin; provides
Prior art date: 1991-08-26

Application number

DK92918163.4T

Other languages

English (en)

Inventor

Martin Durham Meglasson

Original Assignee

Upjohn Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-08-26

Filing date

1992-08-19

Publication date

1997-10-20

1991-08-26 Priority claimed from US07/751,239 external-priority patent/US6008253A/en

1992-08-19 Application filed by Upjohn Co filed Critical Upjohn Co

1997-10-20 Application granted granted Critical

1997-10-20 Publication of DK0601001T3 publication Critical patent/DK0601001T3/da

Links

KMXXSJLYVJEBHI-UHFFFAOYSA-N 3-guanidinopropanoic acid Chemical compound NC(=[NH2+])NCCC([O-])=O KMXXSJLYVJEBHI-UHFFFAOYSA-N 0.000 title abstract 5
235000021056 liquid food Nutrition 0.000 title 1
229940079593 drug Drugs 0.000 abstract 4
239000003814 drug Substances 0.000 abstract 4
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 4
102000004877 Insulin Human genes 0.000 abstract 2
108090001061 Insulin Proteins 0.000 abstract 2
235000013305 food Nutrition 0.000 abstract 2
229940125396 insulin Drugs 0.000 abstract 2
230000003914 insulin secretion Effects 0.000 abstract 2
HYAFETHFCAUJAY-UHFFFAOYSA-N pioglitazone Chemical compound N1=CC(CC)=CC=C1CCOC(C=C1)=CC=C1CC1C(=O)NC(=O)S1 HYAFETHFCAUJAY-UHFFFAOYSA-N 0.000 abstract 2
230000001235 sensitizing effect Effects 0.000 abstract 2
230000004936 stimulating effect Effects 0.000 abstract 2
208000008589 Obesity Diseases 0.000 abstract 1
GHUUBYQTCDQWRA-UHFFFAOYSA-N Pioglitazone hydrochloride Chemical compound Cl.N1=CC(CC)=CC=C1CCOC(C=C1)=CC=C1CC1C(=O)NC(=O)S1 GHUUBYQTCDQWRA-UHFFFAOYSA-N 0.000 abstract 1
206010067584 Type 1 diabetes mellitus Diseases 0.000 abstract 1
229940127003 anti-diabetic drug Drugs 0.000 abstract 1
239000003472 antidiabetic agent Substances 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
229960004580 glibenclamide Drugs 0.000 abstract 1
WIGIZIANZCJQQY-RUCARUNLSA-N glimepiride Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)N[C@@H]2CC[C@@H](C)CC2)C=C1 WIGIZIANZCJQQY-RUCARUNLSA-N 0.000 abstract 1
229960004346 glimepiride Drugs 0.000 abstract 1
ZNNLBTZKUZBEKO-UHFFFAOYSA-N glyburide Chemical compound COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZNNLBTZKUZBEKO-UHFFFAOYSA-N 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
235000020824 obesity Nutrition 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
229960005095 pioglitazone Drugs 0.000 abstract 1
229960002827 pioglitazone hydrochloride Drugs 0.000 abstract 1
230000007103 stamina Effects 0.000 abstract 1
208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Pharmacology & Pharmacy (AREA)
Polymers & Plastics (AREA)
Food Science & Technology (AREA)
Nutrition Science (AREA)
Engineering & Computer Science (AREA)
Mycology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)

DK92918163.4T 1991-08-26 1992-08-19 Flydende næringsmiddelprodukt indeholdende 3-guanidinopropionsyre. DK0601001T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US75055991A	1991-08-26	1991-08-26
US07/751,239 US6008253A (en)	1991-08-26	1991-08-26	Use of 3-guanidinopropionic acid to increase endurance, stamina and exercise capacity in a mammal

Publications (1)

Publication Number	Publication Date
DK0601001T3 true DK0601001T3 (da)	1997-10-20

Family

ID=27115296

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK92918163.4T DK0601001T3 (da)	1991-08-26	1992-08-19	Flydende næringsmiddelprodukt indeholdende 3-guanidinopropionsyre.

Country Status (10)

Country	Link
US (1)	US5900435A (da)
EP (1)	EP0601001B1 (da)
JP (1)	JPH06510286A (da)
AT (1)	ATE151634T1 (da)
AU (1)	AU2479492A (da)
DE (1)	DE69219136T2 (da)
DK (1)	DK0601001T3 (da)
ES (1)	ES2101866T3 (da)
GR (1)	GR3023848T3 (da)
WO (1)	WO1993003724A1 (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1991012799A1 (en) *	1990-02-28	1991-09-05	The Upjohn Company	Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders
TWI238064B (en)	1995-06-20	2005-08-21	Takeda Chemical Industries Ltd	A pharmaceutical composition for prophylaxis and treatment of diabetes
JP2000511177A (ja) *	1996-05-21	2000-08-29	ファルマシア・アンド・アップジョン・カンパニー	インスリン非依存性糖尿病治療のためのアミノグアニジンカルボキシレートラクタム類
PL331148A1 (en) *	1996-07-12	1999-06-21	Smithkline Beecham Plc	Novel method of treating the leptin immunity
WO1998020871A1 (fr) *	1996-11-08	1998-05-22	Nippon Chemiphar Co., Ltd.	Agent diminuant la graisse viscerale
US7910548B2 (en) *	1997-06-06	2011-03-22	Amylin Pharmaceuticals, Inc.	Methods for treating obesity
EA003025B1 (ru) *	1997-06-18	2002-12-26	Смитклайн Бичам Плс	Лечение диабета тиазолидиндионом и сульфонилмочевиной
CA2294134A1 (en) *	1997-06-18	1998-12-23	Stephen Alistair Smith	Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor
US20010049380A1 (en) *	1997-06-18	2001-12-06	Smith Stephen Alistair	Treatment of diabetes with thiazolidinedione and sulphonylurea
US20020004515A1 (en) *	1997-06-18	2002-01-10	Smith Stephen Alistair	Treatment of diabetes with thiazolidinedione and metformin
KR100666591B1 (ko) *	1997-06-18	2007-01-11	스미스클라인비이참피이엘시이	티아졸리딘디온 및 메트포르민을 사용한 당뇨병의 치료
US20020016287A1 (en) *	1997-07-18	2002-02-07	Smithkline Beecham P.L.C.	Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide
GB9715298D0 (en) *	1997-07-18	1997-09-24	Smithkline Beecham Plc	Novel method of treatment
GB9715306D0 (en) *	1997-07-18	1997-09-24	Smithkline Beecham Plc	Novel method of treatment
GB9715295D0 (en) *	1997-07-18	1997-09-24	Smithkline Beecham Plc	Novel method of treatment
EP1093370B1 (en)	1998-06-30	2006-02-22	Takeda Pharmaceutical Company Limited	Pharmaceutical composition for the treatment of diabetes
US20040102486A1 (en) *	1998-11-12	2004-05-27	Smithkline Beecham Corporation	Novel method of treatment
GB9824893D0 (en) *	1998-11-12	1999-01-06	Smithkline Beckman Corp	Novel method of treatment
US6667064B2 (en) *	2000-08-30	2003-12-23	Pilot Therapeutics, Inc.	Composition and method for treatment of hypertriglyceridemia
US9060941B2 (en)	2002-09-20	2015-06-23	Actavis, Inc.	Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7504118B2 (en) *	2003-04-11	2009-03-17	Fhg Corporation	Dietary supplements containing extracts of cinnamon and methods of using same to enhance creatine transport
JP2008533196A (ja) *	2005-03-19	2008-08-21	ヨンチャン，セ	肥満または高脂血症の予防及び治療用の組成物、ならびに、肥満、高脂血症、または心循環系疾患の予防及び改善用の健康機能性食品
WO2012138214A1 (en) *	2011-04-08	2012-10-11	Brewster Lizzy Maritza	Beta-guanidinopropionic acid for the treatment of hypertension
EP2910130B1 (en) *	2012-10-18	2018-08-15	Nissin Foods Holdings Co., Ltd.	Salty taste-enhancing agent and manufacturing method therefor, and salty taste-enhancing method
JP2023505687A (ja) *	2019-12-11	2023-02-10	インスピルナ，インコーポレーテッド	癌の処置方法
CN113598232A (zh) *	2021-07-05	2021-11-05	安徽科技学院	一种非发酵凝固型甜酒风味奶及其生产方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1195199A (en) *	1966-11-25	1970-06-17	Horlicks Pharmaceuticals Ltd	Improvements in Compositions comprising Insulin.
GB1195200A (en) *	1967-02-07	1970-06-17	Horlicks Pharmaceuticals Ltd	Pharmaceutical Compositions.
US3843798A (en) *	1973-03-12	1974-10-22	Stanley Drug Products Inc	Methods and compositions for inducing resistance to bacterial infections
GB1552179A (en) *	1976-11-02	1979-09-12	Beecham Group Ltd	Pharmaceutical compositions for treating hyperglycaemia
US5053420A (en) *	1989-10-13	1991-10-01	Pershadsingh Harrihar A	Thiazolidine derivatives for the treatment of hypertension
IT1237519B (it) *	1989-11-27	1993-06-08		Impiego dell'acido guanidinacetico per indurre un incremento del contenuto muscolare di creatina
WO1991012799A1 (en) *	1990-02-28	1991-09-05	The Upjohn Company	Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders
GB9003185D0 (en) *	1990-02-13	1990-04-11	Ici Plc	Pharmaceutical compositions

1992
- 1992-08-19 DK DK92918163.4T patent/DK0601001T3/da active
- 1992-08-19 ES ES92918163T patent/ES2101866T3/es not_active Expired - Lifetime
- 1992-08-19 US US08/196,250 patent/US5900435A/en not_active Expired - Fee Related
- 1992-08-19 AU AU24794/92A patent/AU2479492A/en not_active Abandoned
- 1992-08-19 JP JP5504419A patent/JPH06510286A/ja active Pending
- 1992-08-19 DE DE69219136T patent/DE69219136T2/de not_active Expired - Fee Related
- 1992-08-19 WO PCT/US1992/006776 patent/WO1993003724A1/en active IP Right Grant
- 1992-08-19 AT AT92918163T patent/ATE151634T1/de not_active IP Right Cessation
- 1992-08-19 EP EP92918163A patent/EP0601001B1/en not_active Expired - Lifetime
1997
- 1997-06-19 GR GR970401487T patent/GR3023848T3/el unknown

Also Published As

Publication number	Publication date
DE69219136D1 (de)	1997-05-22
JPH06510286A (ja)	1994-11-17
US5900435A (en)	1999-05-04
WO1993003724A1 (en)	1993-03-04
AU2479492A (en)	1993-03-16
GR3023848T3 (en)	1997-09-30
ES2101866T3 (es)	1997-07-16
EP0601001A1 (en)	1994-06-15
DE69219136T2 (de)	1997-08-28
ATE151634T1 (de)	1997-05-15
EP0601001B1 (en)	1997-04-16

Publication	Publication Date	Title
DK0601001T3 (da)	1997-10-20	Flydende næringsmiddelprodukt indeholdende 3-guanidinopropionsyre.
GEP20053538B (en)	2005-06-10	Pharmaceutical Composition Comprising A Combination of Metformin and Glyburide
ATE204178T1 (de)	2001-09-15	Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
JPS61148121A (ja)	1986-07-05	治療用組成物
RU94046251A (ru)	1996-10-27	Глюкагоноподобный пептид и производные инсулино-тропина, способ получений, фармацевтические композиции, способы лечения диабета
YU46761B (sh)	1994-05-10	Postupak za dobijanje piperazinil derivata purina i njihovih izostereomera
JPH06511480A (ja)	1994-12-22	脊椎動物における体脂肪蓄積、インシュリン抵抗、高インシュリン、及び高血糖の長期削減のための改良された方法
NO972128D0 (no)	1997-05-07	2,2-dikloralkankarboksylsyrer, fremgangsmåte for fremstilling av disse, legemiddel inneholdende disse og anvendelse derav for behandling av insulinresistens
PT808164E (pt)	2005-05-31	Utilizacao de moduladores da prolactina e dieta para o fabrico de um medicamento destinado ao tratamento da obesidade
HUT66826A (en)	1995-01-30	Human il-4 mutant proteins, thats containing pharmaceutical product and process for producing of proteins
MXPA04007183A (es)	2006-03-06	Composicion farmaceutica para el control de la glucosa en sangre de pacientes con diabetes tipo 2.
US3928578A (en)	1975-12-23	Composition for control of white muscle disease
Maxeiner et al.	1997	Lethal suicidal intoxication with propafenone, after a history of self-inflicted injuries
ATE143947T1 (de)	1996-10-15	N-acylpyrrolidine und arzneimittel zur behandlung oder prophylaxe von mit ckk und gastrin in zusammenhang stehenden krankheiten
Walter	1973	Clinical impressions on treatment of obsessional states with intravenous clomipramine (Anafranil)
JPH06509362A (ja)	1994-10-20	アルファ−ケトルグルタル酸塩の用法
RU94012067A (ru)	1997-03-20	Средство для лечения осложнений инсулинзависимого и инсулиннезависимого сахарного диабета
DE69230790D1 (de)	2000-04-20	Arzneimittel zur Behandlung von durch Babesia verursachten Protozoeninfektionen
US4259322A (en)	1981-03-31	Method of treatment of tuberculosis
Mirtallo et al.	1980	Albumin in TPN solutions: potential savings from a prospective review
US3565560A (en)	1971-02-23	Pharmaceutical preparation containing hydrofuramide and method of using it
US3449499A (en)	1969-06-10	Method for the reduction of glycemia
ASHER	1973	A CLINICAL ASSESSMENT OF ANORECTIC DRUGS
RU2113227C1 (ru)	1998-06-20	Способ лечения ожирения
US3829566A (en)	1974-08-13	Method for control of white muscle disease